摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(4-Hydroxy-6-methyl-pyrimidin-2-yl)-N'-m-tolyl-guanidine | 371922-29-1

中文名称
——
中文别名
——
英文名称
N-(4-Hydroxy-6-methyl-pyrimidin-2-yl)-N'-m-tolyl-guanidine
英文别名
N-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)-N''-(3-methylphenyl)guanidine;2-(4-methyl-6-oxo-1H-pyrimidin-2-yl)-1-(3-methylphenyl)guanidine
N-(4-Hydroxy-6-methyl-pyrimidin-2-yl)-N'-m-tolyl-guanidine化学式
CAS
371922-29-1
化学式
C13H15N5O
mdl
——
分子量
257.295
InChiKey
GLAHTOFLDQJCPY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    19
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    91.9
  • 氢给体数:
    3
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    N-(4-Hydroxy-6-methyl-pyrimidin-2-yl)-N'-m-tolyl-guanidine三氯氧磷 作用下, 生成 N-(4-Chloro-6-methyl-pyrimidin-2-yl)-N'-m-tolyl-guanidine
    参考文献:
    名称:
    Synthesis and structure activity relationship of guanidines as NPY Y5 antagonists
    摘要:
    A series of bis-aryl substituted guanidines have been discovered as potent NPY Y5 antagonists. The SAR and in vitro metabolic stability of these compounds are discussed. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2004.03.012
  • 作为产物:
    参考文献:
    名称:
    Synthesis and structure activity relationship of guanidines as NPY Y5 antagonists
    摘要:
    A series of bis-aryl substituted guanidines have been discovered as potent NPY Y5 antagonists. The SAR and in vitro metabolic stability of these compounds are discussed. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2004.03.012
点击查看最新优质反应信息

文献信息

  • Synthesis and structure activity relationship of guanidines as NPY Y5 antagonists
    作者:Christopher J Aquino、Joshi M Ramanjulu、Dennis Heyer、Alejandro J Daniels、Fabio Palazzo、Milana Dezube
    DOI:10.1016/j.bmc.2004.03.012
    日期:2004.5
    A series of bis-aryl substituted guanidines have been discovered as potent NPY Y5 antagonists. The SAR and in vitro metabolic stability of these compounds are discussed. (C) 2004 Elsevier Ltd. All rights reserved.
查看更多